Heparin Sodium and 0.9% Sodium Chloride Injection (2020-01-31)
- Starting date:
- January 31, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-74263
Last updated:
2020-11-03
Summary
-
Product:
Heparin Sodium and 0.9% Sodium Chloride Injection
Reason
The affected lot was inadvertently distributed to the market.
Depth of distribution
Healthcare establishments
Affected products
Heparin Sodium and 0.9% Sodium Chloride Injection
DIN, NPN, DIN-HIM
DIN 00828750
Dosage form
Solution
Strength
Heparin (Heparin Sodium) 2 UNIT / ML
Sodium Chloride 9 MG / ML
Lot or serial number
W9J03B1
Companies
- Recalling Firm
-
Baxter Corporation
7125 Mississauga Road
Mississauga
L5N 0C2
Ontario
CANADA
- Marketing Authorization Holder
-
Baxter Corporation
7125 Mississauga Road
Mississauga
L5N 0C2
Ontario
CANADA